US Edition
The Pharmaceutical Manufacturer Received Good News, People Suffering From Alzheimer's Disease Will Receive Help
Summary by Portfolio.hu
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The European Medicines Agency (EMA) has recommended for approval Eli Lilly's drug Kisunla for patients with early Alzheimer's disease, reversing its rejection decision four months ago.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
